Share on StockTwits
Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

CannaTech Sydney: Australia's First Ever Global Medical Cannabis Summit

Industry Leaders in Business, Medical Science & Technology to Gather at CannaTech Sydney October 28-30, 2018


Tel Aviv, Israel - September 4, 2018 ( Newswire) As the global medical cannabis market continues to expand exponentially and increasing numbers of countries around the globe legalize its use, Australia's first ever Medical Cannabis Summit will take place in Sydney, October 28-30, 2018 at Doltone House Darling Island Wharf, a unique heritage venue situated on Sydney's Pyrmont Harbour overlooking the Harbour Bridge and city skyline.

CannaTech Sydney will bring together industry leaders from Australia and around the world known for their significant and ground-breaking contributions to the global medical cannabis market in all fields.

The Summit will cover the most current industry topics including Ag Tech & Innovation, Business & Finance, Policy & Regulation, Science & Medicine. Human interest stories will be an important component of the program.

A special business focused symposium will take place on Sunday, October 28.

Click here for a list of CannaTech Sydney speakers and daily schedule.

"Australia is a key and growing player in the exploding cannabis field. Many Australian cannabis companies are on the cutting edge of the market and we are thrilled to bring some of the world's leading companies and investors to Australia to meet with their counterparts to discuss a range of business and technological issues. As a native Aussie myself, I could not be more proud to bring CannaTech to my country of birth and work with like minded professionals who understand the immense global health and business potential of medical cannabis moving forward," said Saul Kaye, Founder and CEO of iCAN: Israel-Cannabis.

iCAN is proud to partner with Buddingtech, Australia's first medical cannabis accelerator. Adam Miller, CEO of Budding tech said, "I am excited to have the opportunity to be part of CannaTech Sydney, Australia's first medical cannabis conference of international scale. Australia is well positioned to become a world leader in the production, manufacturing and export of cannabis due to its strong workforce, high-level academic and research capabilities, and well-developed agricultural skills. CannaTech will allow us to showcase our capabilities in this burgeoning industry."

About iCAN: Israel-Cannabis

iCAN is building the global cannabis ecosystem. iCAN identifies and accelerates innovative medical cannabis technologies and creates synergies and cooperation across the industry. iCAN uses its global network and reach to position Israel as the leading medical cannabis tech hub.

About CannaTech

CannaTech is powered by iCAN. CannaTech is the premier international cannabis summit held annually in Tel Aviv, and internationally in London, Panama, and for the first time in Sydney, Australia in October 2018 and Hong Kong in November 2018.

For further information, media inquiries and journalist registration contact:

Laura Kam, +972-54-806-8613.

Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy:

Follow Us on StockTwits